AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 45 filers reported holding AGILE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $0 | -100.0% | 59 | -99.2% | 0.00% | – |
Q3 2021 | $6,000 | -60.0% | 7,054 | -35.8% | 0.00% | – |
Q2 2021 | $15,000 | -88.1% | 10,990 | -81.9% | 0.00% | – |
Q1 2021 | $126,000 | +223.1% | 60,684 | +345.3% | 0.00% | – |
Q4 2020 | $39,000 | +105.3% | 13,629 | +124.1% | 0.00% | – |
Q3 2020 | $19,000 | -73.6% | 6,082 | -76.7% | 0.00% | – |
Q2 2020 | $72,000 | -42.4% | 26,126 | -61.0% | 0.00% | – |
Q1 2020 | $125,000 | +557.9% | 66,968 | +1199.8% | 0.00% | – |
Q2 2017 | $19,000 | -17.4% | 5,152 | -29.7% | 0.00% | – |
Q1 2017 | $23,000 | +130.0% | 7,332 | +302.0% | 0.00% | – |
Q4 2016 | $10,000 | +66.7% | 1,824 | +127.7% | 0.00% | – |
Q3 2016 | $6,000 | +100.0% | 801 | +126.9% | 0.00% | – |
Q2 2016 | $3,000 | +50.0% | 353 | +40.1% | 0.00% | – |
Q4 2015 | $2,000 | +100.0% | 252 | +93.8% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 130 | -54.7% | 0.00% | – |
Q2 2015 | $2,000 | – | 287 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |